These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11063825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
    Rep MH, Schrijver HM, van Lopik T, Hintzen RQ, Roos MT, Adèr HJ, Polman CH, van Lier RA.
    J Neuroimmunol; 1999 Apr 01; 96(1):92-100. PubMed ID: 10227428
    [Abstract] [Full Text] [Related]

  • 5. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 6. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.
    Schuerwegh AJ, De Clerck LS, Bridts CH, Stevens WJ.
    Clin Exp Allergy; 2001 May 15; 31(5):740-6. PubMed ID: 11422133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
    Skrzipek S, Vogelgesang A, Bröker BM, Dressel A.
    Mult Scler; 2012 May 15; 18(5):674-8. PubMed ID: 22025329
    [Abstract] [Full Text] [Related]

  • 9. Immunomodulatory effects of IFN-beta1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS).
    Pede PD, Visintini D, Telera A, Cucurachi L, Campanini C, Immovilli P, Vescovini R, Sansoni P.
    J Interferon Cytokine Res; 2005 Aug 15; 25(8):485-9. PubMed ID: 16108731
    [Abstract] [Full Text] [Related]

  • 10. CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis.
    Sellebjerg F, Ross C, Koch-Henriksen N, Sørensen PS, Frederiksen JL, Bendtzen K, Sørensen TL.
    Mult Scler; 2005 Dec 15; 11(6):641-5. PubMed ID: 16320722
    [Abstract] [Full Text] [Related]

  • 11. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F, Di Marco R, Patti F, Zaccone P, L'Episcopo MR, Reggio E, Xiang M, Nicoletti A, Reggio A.
    Cytokine; 2000 Jun 15; 12(6):682-7. PubMed ID: 10843745
    [Abstract] [Full Text] [Related]

  • 12. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis.
    Sepulcre J, Sanchez-Ibarrola A, Moreno C, de Castro P.
    Cytokine; 2005 Oct 21; 32(2):111-6. PubMed ID: 16246570
    [Abstract] [Full Text] [Related]

  • 13. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
    Brinkmann V, Geiger T, Alkan S, Heusser CH.
    J Exp Med; 1993 Nov 01; 178(5):1655-63. PubMed ID: 8228812
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
    Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL.
    J Neuroimmunol; 2004 Jan 01; 146(1-2):189-98. PubMed ID: 14698862
    [Abstract] [Full Text] [Related]

  • 15. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y, Iwabuchi K, Kikuchi S, Fukazawa T, Niino M, Hirotani M, Sasaki H, Onoé K.
    Mult Scler; 2008 Sep 01; 14(8):1044-55. PubMed ID: 18573819
    [Abstract] [Full Text] [Related]

  • 16. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
    Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG, Mair R, Christakos A, Kolkowitz I, Katz L, Killestein J, Polman CH, de Waal Malefyt R, Steinman L, Raman C.
    Nat Med; 2010 Apr 01; 16(4):406-12. PubMed ID: 20348925
    [Abstract] [Full Text] [Related]

  • 17. Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis.
    Kress-Bennett JM, Ehrlich GD, Bruno A, Post JC, Hu FZ, Scott TF.
    BMC Neurol; 2011 Dec 19; 11():155. PubMed ID: 22182694
    [Abstract] [Full Text] [Related]

  • 18. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.
    García-León JA, López-Gómez C, Orpez-Zafra T, Reyes-Garrido V, Marín-Bañasco C, Oliver-Martos B, Fernández O, Leyva L.
    CNS Drugs; 2014 Jun 19; 28(6):559-70. PubMed ID: 24599774
    [Abstract] [Full Text] [Related]

  • 19. Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
    Laribi B, Sahraian MA, Shekarabi M, Emamnejad R, Marzban M, Sadaghiani S, Izad M.
    Iran J Allergy Asthma Immunol; 2018 Aug 12; 17(4):346-360. PubMed ID: 30537798
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones.
    Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G.
    J Exp Med; 1994 Apr 01; 179(4):1273-83. PubMed ID: 7908322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.